188 related articles for article (PubMed ID: 36949064)
1. Epigenetic state determines the in vivo efficacy of STING agonist therapy.
Falahat R; Berglund A; Perez-Villarroel P; Putney RM; Hamaidi I; Kim S; Pilon-Thomas S; Barber GN; Mulé JJ
Nat Commun; 2023 Mar; 14(1):1573. PubMed ID: 36949064
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.
Falahat R; Berglund A; Putney RM; Perez-Villarroel P; Aoyama S; Pilon-Thomas S; Barber GN; Mulé JJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33827917
[TBL] [Abstract][Full Text] [Related]
3. EZH2 Inhibitor Enhances the STING Agonist‒Induced Antitumor Immunity in Melanoma.
Xu T; Dai J; Tang L; Yang L; Si L; Sheng X; Cui C; Chi Z; Kong Y; Guo J
J Invest Dermatol; 2022 Apr; 142(4):1158-1170.e8. PubMed ID: 34571002
[TBL] [Abstract][Full Text] [Related]
4. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
[TBL] [Abstract][Full Text] [Related]
5. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
6. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
7. STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.
Wilski NA; Stotesbury C; Del Casale C; Montoya B; Wong E; Sigal LJ; Snyder CM
J Immunol; 2020 Jun; 204(11):2961-2972. PubMed ID: 32284333
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING.
Tian J; Zhang D; Kurbatov V; Wang Q; Wang Y; Fang D; Wu L; Bosenberg M; Muzumdar MD; Khan S; Lu Q; Yan Q; Lu J
EMBO J; 2021 Apr; 40(7):e106065. PubMed ID: 33615517
[TBL] [Abstract][Full Text] [Related]
9. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
Ohkuri T; Ghosh A; Kosaka A; Zhu J; Ikeura M; David M; Watkins SC; Sarkar SN; Okada H
Cancer Immunol Res; 2014 Dec; 2(12):1199-208. PubMed ID: 25300859
[TBL] [Abstract][Full Text] [Related]
10. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
[TBL] [Abstract][Full Text] [Related]
11. STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity.
Falahat R; Perez-Villarroel P; Mailloux AW; Zhu G; Pilon-Thomas S; Barber GN; Mulé JJ
Cancer Immunol Res; 2019 Nov; 7(11):1837-1848. PubMed ID: 31462408
[TBL] [Abstract][Full Text] [Related]
12. Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release.
Xu L; Li M; Yang Y; Zhang C; Xie Z; Tang J; Shi Z; Chen S; Li G; Gu Y; Wang X; Zhang F; Wang Y; Shen X
mBio; 2022 Jun; 13(3):e0363221. PubMed ID: 35604097
[TBL] [Abstract][Full Text] [Related]
13. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
[TBL] [Abstract][Full Text] [Related]
14. STING Signaling in Cancer Cells: Important or Not?
Sokolowska O; Nowis D
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
[TBL] [Abstract][Full Text] [Related]
15. MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling.
Ghukasyan R; Liang K; Chau K; Li L; Chan C; Abt ER; Le T; Park JY; Wu N; Premji A; Damoiseaux R; Luu T; Labora A; Rashid K; Link JM; Radu CG; Donahue TR
Clin Cancer Res; 2023 Aug; 29(16):3130-3141. PubMed ID: 37195712
[TBL] [Abstract][Full Text] [Related]
16. Novel chemical compound SINCRO with dual function in STING-type I interferon and tumor cell death pathways.
Kimura Y; Negishi H; Matsuda A; Endo N; Hangai S; Inoue A; Nishio J; Taniguchi T; Yanai H
Cancer Sci; 2018 Sep; 109(9):2687-2696. PubMed ID: 29981256
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis.
Xia T; Konno H; Barber GN
Cancer Res; 2016 Nov; 76(22):6747-6759. PubMed ID: 27680683
[TBL] [Abstract][Full Text] [Related]
18. TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.
Francica BJ; Ghasemzadeh A; Desbien AL; Theodros D; Sivick KE; Reiner GL; Hix Glickman L; Marciscano AE; Sharabi AB; Leong ML; McWhirter SM; Dubensky TW; Pardoll DM; Drake CG
Cancer Immunol Res; 2018 Apr; 6(4):422-433. PubMed ID: 29472271
[TBL] [Abstract][Full Text] [Related]
19. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T
Benoit-Lizon I; Jacquin E; Rivera Vargas T; Richard C; Roussey A; Dal Zuffo L; Martin T; Melis A; Vinokurova D; Shahoei SH; Baeza Garcia A; Pignol C; Giorgiutti S; Carapito R; Boidot R; Végran F; Flavell RA; Ryffel B; Nelson ER; Soulas-Sprauel P; Lawrence T; Apetoh L
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091453
[TBL] [Abstract][Full Text] [Related]
20. Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity.
Kim JC; Liu X; Fitzgerald K; Eng JS; Orf J; O'Brien SA; Belmontes B; Casbon AJ; Novitskiy SV; Tarbell KV; DeVoss J; Egen JG
Cancer Immunol Immunother; 2023 May; 72(5):1327-1335. PubMed ID: 36394642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]